These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 3104387)

  • 21. Hormonal responses to the new potent GnRH antagonist Cetrorelix.
    Klingmüller D; Schepke M; Enzweiler C; Bidlingmaier F
    Acta Endocrinol (Copenh); 1993 Jan; 128(1):15-8. PubMed ID: 8447189
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Regulation of pituitary glycoprotein alpha-subunit secretion after administration of a luteinizing hormone-releasing hormone antagonist in normal men.
    Lindner J; Rivier JE; Vale WW; Pavlou SN
    J Clin Endocrinol Metab; 1990 Apr; 70(4):1219-24. PubMed ID: 1690747
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Marked suppression of gonadotropins and testosterone by an antagonist analog of gonadotropin-releasing hormone in men.
    Salameh W; Bhasin S; Steiner B; McAdams LA; Peterson M; Swerdloff R
    Fertil Steril; 1991 Jan; 55(1):156-64. PubMed ID: 1898888
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Intermittent long-term administration of a potent gonadotropin-releasing hormone agonist in normal men.
    Doelle G; Linde R; Alexander N; Kirchner F; Vale W; Rivier J; Rabin D
    Int J Fertil; 1982; 27(4):234-7. PubMed ID: 6131043
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Gonadotropin gene expression and secretion in gonadotropin-releasing hormone antagonist-treated male rats: effect of sex steroid replacement.
    Perheentupa A; Huhtaniemi I
    Endocrinology; 1990 Jun; 126(6):3204-9. PubMed ID: 1693570
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Hormonal effects of single gonadotropin-releasing hormone antagonist doses in men.
    Jockenhövel F; Bhasin S; Steiner BS; Rivier JE; Vale WW; Swerdloff RS
    J Clin Endocrinol Metab; 1988 May; 66(5):1065-70. PubMed ID: 3129447
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Pituitary-testicular responses of estradiol-17 beta-implanted bull calves to continuous versus pulsatile infusion of luteinizing hormone releasing hormone.
    Schanbacher BD
    J Anim Sci; 1984 Apr; 58(4):943-8. PubMed ID: 6427169
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Comparison of a gonadotropin releasing-hormone antagonist plus testosterone (T) versus T alone as potential male contraceptive regimens.
    Bagatell CJ; Matsumoto AM; Christensen RB; Rivier JE; Bremner WJ
    J Clin Endocrinol Metab; 1993 Aug; 77(2):427-32. PubMed ID: 8345047
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Gonadotropin and alpha-subunit responses to chronic gonadotropin-releasing hormone analog administration in patients with glycoprotein hormone-secreting pituitary tumors.
    Klibanski A; Jameson JL; Biller BM; Crowley WF; Zervas NT; Rivier J; Vale WW; Bikkal H
    J Clin Endocrinol Metab; 1989 Jan; 68(1):81-6. PubMed ID: 2535852
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Maintenance of the ratio of bioactive to immunoreactive follicle-stimulating hormone in normal men during chronic luteinizing hormone-releasing hormone agonist administration.
    Pavlou SN; Dahl KD; Wakefield G; Rivier J; Vale W; Hsueh AJ; Lindner J
    J Clin Endocrinol Metab; 1988 May; 66(5):1005-9. PubMed ID: 2834409
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The stimulatory and down-regulatory effects of a gonadotropin-releasing hormone agonist in man.
    Heber D; Bhasin S; Steiner B; Swerdloff RS
    J Clin Endocrinol Metab; 1984 Jun; 58(6):1084-8. PubMed ID: 6233295
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Serum LH and FSH response in four-hour infusions of luteinizing hormone-releasing hormone in normal men, Sertoli cell only syndrome, and Klinefelter's syndrome.
    de Kretser DM; Burger HG; Dumpys R
    J Clin Endocrinol Metab; 1975 Nov; 41(5):876-86. PubMed ID: 1102553
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effects of chronic testosterone administration in normal men: safety and efficacy of high dosage testosterone and parallel dose-dependent suppression of luteinizing hormone, follicle-stimulating hormone, and sperm production.
    Matsumoto AM
    J Clin Endocrinol Metab; 1990 Jan; 70(1):282-7. PubMed ID: 2104626
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Testosterone administration inhibits gonadotropin secretion by an effect directly on the human pituitary.
    Sheckter CB; Matsumoto AM; Bremner WJ
    J Clin Endocrinol Metab; 1989 Feb; 68(2):397-401. PubMed ID: 2493030
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Long term treatment of male and female precocious puberty by periodic administration of a long-acting preparation of D-Trp6-luteinizing hormone-releasing hormone microcapsules.
    Roger M; Chaussain JL; Berlier P; Bost M; Canlorbe P; Colle M; Francois R; Garandeau P; Lahlou N; Morel Y
    J Clin Endocrinol Metab; 1986 Apr; 62(4):670-7. PubMed ID: 2936759
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Evidence for decreased luteinizing hormone-releasing hormone pulse frequency in men with selective elevations of follicle-stimulating hormone.
    Gross KM; Matsumoto AM; Southworth MB; Bremner WJ
    J Clin Endocrinol Metab; 1985 Jan; 60(1):197-202. PubMed ID: 3917266
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Postcastration rise in plasma gonadotropins is blocked by a luteinizing hormone-releasing hormone antagonist.
    Condon TP; Sawyer CH; Heber D; Stewart JM; Whitmoyer DI
    Biol Reprod; 1985 Oct; 33(3):715-21. PubMed ID: 3931713
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The role of estrogen in the modulation of pituitary sensitivity of LRF (luteinizing hormone-releasing factor) in men.
    Wang CF; Lasley BL; Yen SS
    J Clin Endocrinol Metab; 1975 Jul; 41(1):41-3. PubMed ID: 1097463
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Gonadotropin subunit messenger RNA concentrations after blockade of gonadotropin-releasing hormone action: testosterone selectively increases follicle-stimulating hormone beta-subunit messenger RNA by posttranscriptional mechanisms.
    Paul SJ; Ortolano GA; Haisenleder DJ; Stewart JM; Shupnik MA; Marshall JC
    Mol Endocrinol; 1990 Dec; 4(12):1943-55. PubMed ID: 1707128
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Direct and indirect inhibition of ovulation in rats by an antagonist of luteinizing hormone-releasing hormone.
    Nekola MV; Coy DH
    Endocrinology; 1985 Feb; 116(2):756-60. PubMed ID: 3917910
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.